7VRK
crystal structure of BRD2-BD1 in complex with purine derivative
Summary for 7VRK
Entry DOI | 10.2210/pdb7vrk/pdb |
Descriptor | Bromodomain-containing protein 2, THEOPHYLLINE, SULFATE ION, ... (4 entities in total) |
Functional Keywords | bet family, bet inhibitor, bromodomain inhibitor, brd2-bd1 inhibitor, transcription-inhibitor complex, transcription/inhibitor |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 3 |
Total formula weight | 45568.80 |
Authors | Padmanabhan, B.,Arole, A.,Deshmukh, P.,Ashok, S.,Mathur, S. (deposition date: 2021-10-23, release date: 2023-02-01, Last modification date: 2023-11-29) |
Primary citation | Arole, A.H.,Deshmukh, P.,Sridhar, A.,Mathur, S.,Mahalingaswamy, M.,Subramanya, H.,Dalavaikodihalli Nanjaiah, N.,Padmanabhan, B. Structural and biochemical insights into purine-based drug molecules in hBRD2 delineate a unique binding mode opening new vistas in the design of inhibitors of the BET family. Acta Crystallogr D Struct Biol, 79:758-774, 2023 Cited by PubMed: 37432115DOI: 10.1107/S2059798323005211 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.48 Å) |
Structure validation
Download full validation report